BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 13912814)

  • 1. Neuropathological observations in maple syrup urine disease: branched-chain ketoaciduria.
    SILBERMAN J; DANCIS J; FEIGIN I
    Arch Neurol; 1961 Oct; 5():351-63. PubMed ID: 13912814
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and biochemical observations on an apparently nonfatal variant of branched-chain ketoaciduria (maple syrup urine disease).
    MORRIS MD; LEWIS BD; DOOLAN PD; HARPER HA
    Pediatrics; 1961 Dec; 28():918-23. PubMed ID: 14476272
    [No Abstract]   [Full Text] [Related]  

  • 3. Maple syrup urine disease: branched-chain keto-aciduria.
    DANCIS J; LEVITZ M; WESTALL RG
    Pediatrics; 1960 Jan; 25():72-9. PubMed ID: 13813934
    [No Abstract]   [Full Text] [Related]  

  • 4. [CLINICAL, BIOCHEMICAL, AND NEUROPATHOLOGIC ASPECTS OF MAPLE SYRUP URINE DISEASE. A KETOACIDURIA OF THE OPEN CHAIN AMINOACIDS LEUCINE, ISOLEUCINE AND VALINE].
    SILBERMANSCHWARTZMAN J
    An Fac Med Lima; 1963 Sep; 46():339-65. PubMed ID: 14122039
    [No Abstract]   [Full Text] [Related]  

  • 5. A new variant of maple syrup urine disease (branched chain ketoaciduria). Clinical and biochemical evaluation.
    Schulman JD; Lustberg TJ; Kennedy JL; Museles M; Seegmiller JE
    Am J Med; 1970 Jul; 49(1):118-24. PubMed ID: 5431474
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical and biochemical-genetic aspects of intermittent branched-chain ketoaciduria. Report of two Scandinavian families.
    Goedde HW; Langenbeck U; Brackertz D; Keller W; Rokkones T; Halvorsen S; Kiil R; Merton B
    Acta Paediatr Scand; 1970 Jan; 59(1):83-7. PubMed ID: 5452306
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of thiamine in a patient with a variant form of branched-chian ketoaciduria.
    Duran M; Tielens AG; Wadman SK; Stigter JC; Kleijer WJ
    Acta Paediatr Scand; 1978 May; 67(3):367-72. PubMed ID: 654914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal dialysis in maple-syrup-urine disease: studies on branched-chain amino and keto acids.
    Wendel U; Becker K; Przyrembel H; Bulla M; Manegold C; Mench-Hoinowski A; Langenbeck U
    Eur J Pediatr; 1980 Jun; 134(1):57-63. PubMed ID: 7408911
    [No Abstract]   [Full Text] [Related]  

  • 9. The gas-chromatographic diagnosis of intermittent maple syrup urine disease (branch-chain ketoaciduria).
    Gompertz D; Draffan GH
    Clin Chim Acta; 1972 Aug; 40(1):5-11. PubMed ID: 5056643
    [No Abstract]   [Full Text] [Related]  

  • 10. Late-onset branched-chain ketoaciduria: (maple syrup urine disease).
    Morris MD; Fisher DA; Fiser R
    J Lancet; 1966 Mar; 86(3):149-52. PubMed ID: 5904649
    [No Abstract]   [Full Text] [Related]  

  • 11. Biochemical studies on a variant of branched chain ketoaciduria in a 19-year-old female.
    Fischer MH; Gerritsen T
    Pediatrics; 1971 Nov; 48(5):795-801. PubMed ID: 5125877
    [No Abstract]   [Full Text] [Related]  

  • 12. Family with intermittent maple syrup urine disease.
    Valman HB; Patrick AD; Seakins JW; Platt JW; Gompertz D
    Arch Dis Child; 1973 Mar; 48(3):225-8. PubMed ID: 4693464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiamine non-responsive intermittent branched-chain ketoaciduria in a Laotian child.
    Pueschel SM
    J Inherit Metab Dis; 1986; 9(1):72. PubMed ID: 3088326
    [No Abstract]   [Full Text] [Related]  

  • 14. Leucine equivalency system in managing branched chain ketoaciduria.
    Smith BA; Waisman HA
    J Am Diet Assoc; 1971 Oct; 59(4):342-6. PubMed ID: 5095277
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the clinical picture and pathological anatomy of the maple syrup disease ("branded chain ketoaciduria"). Report on 2 cases in 1 family].
    Sander C; Clotten R; Noetzel H; Wehinger H
    Dtsch Med Wochenschr; 1968 May; 93(18):895-903 passim. PubMed ID: 5650843
    [No Abstract]   [Full Text] [Related]  

  • 16. Maple syrup urine disease.
    Voyce MA; Montgomery JN; Crome L; Bowman J; Ireland JT
    J Ment Defic Res; 1967 Dec; 11(4):231-8. PubMed ID: 5582924
    [No Abstract]   [Full Text] [Related]  

  • 17. Branched-chain alpha-keto acids isolated as oxime derivatives: relationship to the corresponding hydroxy acids and amino acids in maple syrup urine disease.
    Lancaster G; Mamer OA; Scriver CR
    Metabolism; 1974 Mar; 23(3):257-65. PubMed ID: 4813956
    [No Abstract]   [Full Text] [Related]  

  • 18. THE DIAGNOSIS OF MAPLE SYRUP URINE DISEASE (BRANCHED- CHAIN KETOACIDURIA) BY THE IN VITRO STUDY OF THE PERIPHERAL LEUKOCYTE.
    DANCIS J; HUTZLER J; LEVITZ M
    Pediatrics; 1963 Aug; 32():234-8. PubMed ID: 14044451
    [No Abstract]   [Full Text] [Related]  

  • 19. Correlations between branched-chain amino acids and branched-chain alpha-keto acids in blood in maple syrup urine disease.
    Langenbeck U; Wendel U; Mench-Hoinowski A; Kuschel D; Becker K; Przyrembel H; Bremer HJ
    Clin Chim Acta; 1978 Sep; 88(2):283-91. PubMed ID: 699323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exchange transfusion in acute episodes of maple syrup urine disease. Studies on branched-chain amino and keto acids.
    Wendel U; Langenbeck U; Lombeck I; Bremer HJ
    Eur J Pediatr; 1982 Jul; 138(4):293-6. PubMed ID: 7128634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.